Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by St. Jude Children's Research Hospital
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Hemophilia of Georgia, Inc.
Children's Hospital of Philadelphia
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT00979238
First received: September 16, 2009
Last updated: November 9, 2016
Last verified: November 2016